BioNTech SE - Depositary Receipt (Common Stock)
US ˙ NasdaqGS ˙ US09075V1026

SecurityBNTX / BioNTech SE - Depositary Receipt (Common Stock)
InstitutionBrighthouse Funds Trust II - Baillie Gifford International Stock Portfolio Class A
Latest Disclosed Ownership58,970 shares
Latest Disclosed Value $ 6,278,535
Brighthouse Funds Trust II - Baillie Gifford International Stock Portfolio Class A reports 6.75% decrease in ownership of BNTX / BioNTech SE - Depositary Receipt (Common Stock)

On August 27, 2025 - Brighthouse Funds Trust II - Baillie Gifford International Stock Portfolio Class A filed a NPORT-P form disclosing ownership of 58,970 shares of BioNTech SE - Depositary Receipt (Common Stock) (US:BNTX) valued at $6,278,536 USD as of June 30, 2025. The entity filed a previous NPORT-P on May 27, 2025 disclosing 63,241 shares of BioNTech SE - Depositary Receipt (Common Stock). This represents a change in shares of -6.75% during the quarter. The current value of the position is $5,194,078 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-08-27 2025-06-30 NP BioNTech SE EC US09075V1026 58,970 -4,271 -6.75 6,279 9.03 0.4522
2025-05-27 2025-03-31 NP BioNTech SE EC US09075V1026 63,241 -3,662 -5.47 5,759 -24.47 0.4377
2025-02-28 2024-12-31 NP BioNTech SE EC US09075V1026 66,903 -4,229 -5.95 7,624 -9.77 0.5735
2024-11-26 2024-09-30 NP BioNTech SE EC US09075V1026 71,132 -3,511 -4.70 8,448 40.85 0.5548
2024-08-29 2024-06-30 NP BioNTech SE EC US09075V1026 74,643 -4,938 -6.20 5,998 -18.29 0.4097
2024-05-28 2024-03-31 NP BioNTech SE EC US09075V1026 79,581 0 0.00 7,341 -12.59 0.4847
2024-02-29 2023-12-31 NP BioNTech SE EC US09075V1026 79,581 -5,197 -6.13 8,399 -8.82 0.5522
2023-11-29 2023-09-30 NP BioNTech SE EC US09075V1026 84,778 0 0.00 9,210 0.66 0.6837
2023-08-28 2023-06-30 NP BioNTech SE EC US09075V1026 84,778 -4,556 -5.10 9,150 -17.77 0.6041
2023-05-26 2023-03-31 NP BioNTech SE EC US09075V1026 89,334 -4,803 -5.10 11,128 -21.31 0.7016
2023-02-28 2022-12-31 NP BioNTech SE EC US09075V1026 94,137 35,987 61.89 14,141 80.30 0.9334
2022-11-28 2022-09-30 NP BioNTech SE EC US09075V1026 58,150 0 0.00 7,843 -9.54 0.5986
2022-08-29 2022-06-30 NP BioNTech SE EC US09075V1026 58,150 4,295 7.98 8,670 -5.61 0.5832
2022-05-26 2022-03-31 NP BioNTech SE EC US09075V1026 53,855 20,353 60.75 9,186 6.36 0.5493
2022-02-25 2021-12-31 NP BioNTech SE EC US09075V1026 33,502 33,502 8,637 0.4430
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.